Working... Menu
Trial record 2 of 5 for:    prostate vaccine ipilimumab

Neoadjuvant PROSTVAC-VF With or Without Ipilimumab for Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02506114
Recruitment Status : Recruiting
First Posted : July 22, 2015
Last Update Posted : June 20, 2018
Information provided by (Responsible Party):
Lawrence Fong, University of California, San Francisco

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2019
  Estimated Study Completion Date : December 2020